HIF-Dependent Antitumorigenic Effect of Antioxidants In Vivo

Targeting HIF-1 for cancer therapy

Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717

Hypoxia signalling in cancer and approaches to enforce tumour regression

Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676

Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing

Guzy, R. D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K. D., Simon, M. C., Hammerling, U., & Schumacker, P. T. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.001 · Cited by 1,545

Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation

Hu, C.-J., Wang, L.-Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9361-9374.2003 · Cited by 1,386

HIF prolyl‐hydroxylase 2 is the key oxygen sensor setting low steady‐state levels of HIF‐1α in normoxia

Berra, E., Benizri, E., Ginouvès, A., Volmat, V., Roux, D., & Pouysségur, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg392 · Cited by 1,348

The antioxidant function of the p53 tumor suppressor

Sablina, A. A., Budanov, A. V., Ilyinskaya, G. V., Agapova, L. S., Kravchenko, J. E., & Chumakov, P. M. (2005) · Nature Medicine · doi:10.1038/nm1320 · Cited by 1,137

A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling

Hummel, M., Bentink, S., Berger, H., Klapper, W., Weßendorf, S., Barth, T. F. E., Bernd, H., Cogliatti, S., Dierlamm, J., Feller, A. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055351 · Cited by 1,002

HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity

Zhang, H., Gao, P., Fukuda, R., Kumar, G., Krishnamachary, B., Zeller, K. I., Dang, C. V., & Semenza, G. L. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.001 · Cited by 885

c-Myc Can Induce DNA Damage, Increase Reactive Oxygen Species, and Mitigate p53 Function

Vafa, O., Wade, M., Kern, S., Beeche, M., Pandita, T. K., Hampton, G. M., & Wahl, G. M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00520-8 · Cited by 876

HIF-2α Promotes Hypoxic Cell Proliferation by Enhancing c-Myc Transcriptional Activity

Gordan, J. D., Bertout, J. A., Hu, C.-J., Diehl, J. A., & Simon, M. C. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.006 · Cited by 781

Antioxidant micronutrients and the risk of renal cell carcinoma in the Women's Health Initiative cohort

Ho, W. J., Simon, M. S., Yildiz, V. O., Shikany, J. M., Kato, I., Beebe‐Dimmer, J., Cetnar, J. P., & Bock, C. H. (2014) · Cancer · doi:10.1002/cncr.29091 · Cited by 31

Ketogenic diet combined with antioxidant N-acetylcysteine inhibits tumor growth in a mouse model of anaplastic thyroid cancer

Aggarwal, A., Yuan, Z., Barletta, J. A., Lorch, J. H., & Nehs, M. A. (2019) · Surgery · doi:10.1016/j.surg.2019.06.042 · Cited by 31

CHCHD4 (MIA40) and the mitochondrial disulfide relay system

Al-Habib, H., & Ashcroft, M. A. (2021) · Biochemical Society Transactions · doi:10.1042/bst20190232 · Cited by 31

Reactive Oxygen Species and Oncoprotein Signaling-A Dangerous Liaison

Chong, S. J. F., Lai, J. X. H., Eu, J. Q., Bellot, G. L., & Pervaiz, S. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7441 · Cited by 30

Diverse antitumor effects of ascorbic acid on cancer cells and the tumor microenvironment

Maekawa, T., Miyake, T., Tani, M., & Üemoto, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.981547 · Cited by 36

L-ascorbic acid: A true substrate for HIF prolyl hydroxylase?

Osipyants, A. I., Poloznikov, A. A., Smirnova, N. A., Hushpulian, D. M., Khristichenko, A. Y., Chubar, T. A., Zakhariants, A. A., Ahuja, M., Gaisina, I. N., Thomas, B., et al. (2017) · Biochimie · doi:10.1016/j.biochi.2017.12.011 · Cited by 31

Increased alveolar epithelial TRAF6 via autophagy-dependent TRIM37 degradation mediates particulate matter-induced lung metastasis

Liu, J., Li, S., Fei, X., Nan, X., Shen, Y., Xiu, H., Cormier, S. A., Lu, C., Guo, C., Wang, S., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1965421 · Cited by 32

Mitochondrial function in melanoma

Theodosakis, N., Micevic, G., Kelly, D. P., & Bosenberg, M. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.06.028 · Cited by 29

Synthesis, characterization and biological activity of new cyclometallated platinum( iv ) iodido complexes

Bauer, E., Domingo, X., Balcells, C. D., Polat, I. H., Crespo, M., Quirante, J., Badı́a, J., Baldomà, L., Font‐Bardía, M., & Cascante, M. (2017) · Dalton Transactions · doi:10.1039/c7dt03448b · Cited by 28

Peroxidan Plays a Tumor-Promoting Role in Oral Squamous Cell Carcinoma

Kurihara‐Shimomura, M., Sasahira, T., Shimomura, H., & Kirita, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155416 · Cited by 32

Myoglobin: From physiological roles to potential implications in cancer

Elkholi, I. E., Elsherbiny, M. E., & Emara, M. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188706 · Cited by 28

Thiol‐based redox proteomics in cancer research

Yuan, K., Liu, Y., Chen, H., Zhang, L., Lan, J., Gao, W. Q., Dou, Q., Nice, E. C., & Huang, C. (2014) · PROTEOMICS · doi:10.1002/pmic.201400164 · Cited by 30

Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Ichim, T. E., Minev, B., Braciak, T. A., Luna, B., Hunninghake, R., Mikirova, N. A., Jackson, J. A., González, M. J., Miranda-Massari, J. R., Alexandrescu, D. T., et al. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-25 · Cited by 26

Alantolactone is a natural product that potently inhibits YAP1/TAZ through promotion of reactive oxygen species accumulation

Nakatani, K., Maehama, T., Nishio, M., Otani, J., Yamaguchi, K., Fukumoto, M., Hikasa, H., Hagiwara, S., Nishina, H., Mak, T. W., et al. (2021) · Cancer Science · doi:10.1111/cas.15079 · Cited by 27

Engineering nanomedicines to inhibit hypoxia-inducible Factor-1 for cancer therapy

Zhang, X., He, C., & Xiang, G. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.01.012 · Cited by 28

Nitric oxide and reactive oxygen species: Clues to target oxidative damage repair defective breast cancers

Somasundaram, V., Nadhan, R., Hemalatha, S. K., Sengodan, S. K., & Srinivas, P. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.03.004 · Cited by 27

Proteomic Analysis of Protein Expression Affected by Peroxiredoxin V Knock-Down in Hypoxic Kidney

Yang, H., Kwon, J. S., Cho, E., Choi, H., Park, C., Park, H., Park, S., Chung, K., Ryoo, Z. Y., Cho, K., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr100190b · Cited by 26

GPX3 expression was down-regulated but positively correlated with poor outcome in human cancers

Hu, Q., Chen, J., Yang, W., Xu, M. L., Zhou, J., Tan, J., & Huang, T. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.990551 · Cited by 28

Antimalarial therapy prevents Myc-induced lymphoma

Dang, C. V. (2007) · Journal of Clinical Investigation · doi:10.1172/jci34503 · Cited by 28

Computational models of VEGF-associated angiogenic processes in cancer

Stefanini, M. O., Qutub, A. A., Gabhann, F. M., & Popel, A. S. (2011) · Mathematical Medicine and Biology A Journal of the IMA · doi:10.1093/imammb/dqq025 · Cited by 26

Methylseleninic acid elevates REDD1 and inhibits prostate cancer cell growth despite AKT activation and mTOR dysregulation in hypoxia

Sinha, I., Allen, J. E., Pinto, J. T., & Sinha, R. (2014) · Cancer Medicine · doi:10.1002/cam4.198 · Cited by 25

Enhanced mitochondrial fission inhibits triple-negative breast cancer cell migration through an ROS-dependent mechanism

Humphries, B. A., Zhang, A., Buschhaus, J. M., Bevoor, A. S., Farfel, A. P., Rajendran, S., Cutter, A. C., & Luker, G. D. (2023) · iScience · doi:10.1016/j.isci.2023.106788 · Cited by 24

A Cystine-Cysteine Intercellular Shuttle Prevents Ferroptosis in xCTKO Pancreatic Ductal Adenocarcinoma Cells

Meira, W., Daher, B., Parks, S. K., Cormerais, Y., Durivault, J., Tambutté, É., Pouysségur, J., & Vučetić, M. (2021) · Cancers · doi:10.3390/cancers13061434 · Cited by 24

The Result of Vitamin C Treatment of Patients with Cancer: Conditions Influencing the Effectiveness

Hunyady, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084380 · Cited by 29

Involvement of redox signalling in tumour cell dormancy and metastasis

Puente-Cobacho, B., Varela‐López, A., Quiles, J. L., & Ramírez, L. V. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10077-9 · Cited by 25

Glutathione Reductase Expression and Its Prognostic Significance in Colon Cancer

Brzozowa-Zasada, M., Piecuch, A., Bajdak-Rusinek, K., Michalski, M., Klymenko, O., Matysiak, N., Janelt, K., & Czuba, Z. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021097 · Cited by 24

Evaluation of Anti-HIF and Anti-Angiogenic Properties of Honokiol for the Treatment of Ocular Neovascular Diseases

Vavilala, D. T., Ponnaluri, V. K. C., Kanjilal, D., & Mukherji, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113717 · Cited by 23

Effects of antioxidants on cancer progression

Schmidt, S., Qiao, X., & Bergö, M. O. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00269-5 · Cited by 25

Bifurcated BACH2 control coordinates mantle cell lymphoma survival and dispersal during hypoxia

Zhang, H., Chen, Z., Miranda, R. N., Medeiros, L. J., & McCarty, N. (2017) · Blood · doi:10.1182/blood-2017-02-767293 · Cited by 24

Paradoxical effects of DNA tumor virus oncogenes on epithelium-derived tumor cell fate during tumor progression and chemotherapy response

Jiang, H., Liu, L.-Y. D., Tang, F., Zhou, Y. L., Liu, H., Lu, C., Feng, D., Zhu, H., Mao, Y., Li, Z., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00787-x · Cited by 24

Searching for New Molecular Targets for Oral Squamous Cell Carcinoma with a View to Clinical Implementation of Precision Medicine

Sasahira, T., Kurihara‐Shimomura, M., Shimojjukoku, Y., Shima, K., & Kirita, T. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12030413 · Cited by 22

Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma

Pang, Y., Lu, T., Xu-Monette, Z. Y., & Young, K. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065493 · Cited by 28

Regulation of Glucose Metabolism in Hepatocarcinogenesis by MicroRNAs

Reyes, R., Motiwala, T., & Jacob, S. T. (2014) · Gene Expression · doi:10.3727/105221614x13919976902093 · Cited by 22

Global Liver Proteomics of Rats Exposed for 5 Days to Phenobarbital Identifies Changes Associated with Cancer and with CYP Metabolism

Dail, M. B., Shack, L. A., Chambers, J. E., & Burgess, S. C. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn198 · Cited by 22

Triethylenetetramine Synergizes with Pharmacologic Ascorbic Acid in Hydrogen Peroxide Mediated Selective Toxicity to Breast Cancer Cell

Wang, L., Luo, X., Li, C., Huang, Y., Xu, P. A., Lloyd‐Davies, L. H., Delplancke, T. D. J., Peng, C. X., Gao, R., Qi, H., et al. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3481710 · Cited by 22

NSAID celecoxib: a potent mitochondrial pro-oxidant cytotoxic agent sensitizing metastatic cancers and cancer stem cells to chemotherapy

Ralph, S. J., Nozuhur, S., Moreno‐Sánchez, R., Enr��quez, S. R., & Pritchard, R. (2018) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2018.42 · Cited by 23

Metformin Results in Diametrically Opposed Effects by Targeting Non-Stem Cancer Cells but Protecting Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma

Kuo, S. Z., Honda, C. O., Li, W. T., Honda, T. K., Kim, E., Altuna, X., Abhold, E. L., Wang‐Rodriguez, J., & Ongkeko, W. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010193 · Cited by 22

Suffocating cancer: hypoxia-associated epimutations as targets for cancer therapy

Thirlwell, C., Schulz, L., Dibra, H. K., & Beck, S. (2011) · Clinical Epigenetics · doi:10.1186/1868-7083-3-9 · Cited by 22

Specific inhibition of HIF activity: can peptides lead the way?

Mylonis, I., Chachami, G., & Simos, G. (2021) · Cancers · doi:10.3390/cancers13030410 · Cited by 21

Comparative study of antioxidants as cancer preventives through inhibition of HIF-1 alpha activity

Upadhyay, J., Kesharwani, R. K., & Misra, K. (2009) · Bioinformation · doi:10.6026/97320630004233 · Cited by 21

Expression and/or activity of the SVCT2 ascorbate transporter may be decreased in many aggressive cancers, suggesting potential utility for sodium bicarbonate and dehydroascorbic acid in cancer therapy

McCarty, M. F. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.07.023 · Cited by 22

High expression of hypoxia inducible factor 1α related with acquired resistant to EGFR tyrosine kinase inhibitors in NSCLC

Jin, Q., Huang, F., Xu, X., He, H., & Zhang, Y. (2021) · Scientific Reports · doi:10.1038/s41598-020-79801-1 · Cited by 21

Practical strategies for suppressing hypoxia-inducible factor activity in cancer therapy

McCarty, M. F., Barroso-Aranda, J., & Contreras, F. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2009.12.022 · Cited by 21

The greedy nature of mutant RAS: a boon for drug discovery targeting cancer metabolism?

Lv, J., Wang, J., Chang, S., Liu, M., & Pang, X. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv102 · Cited by 22

The metabolic switch and its regulation in cancer cells

Zhou, S., Huang, C., & Wei, Y. (2010) · Science China Life Sciences · doi:10.1007/s11427-010-4041-1 · Cited by 21

AKT as locus of fragility in robust cancer system

Radisavljevic, Z. M. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21777 · Cited by 19

Ascorbate availability affects tumor implantation-take rate and increases tumor rejection in Gulo–/– mice

Dachs, G. U., Campbell, E. J., & Vissers, M. C. M. (2016) · Hypoxia · doi:10.2147/hp.s103088 · Cited by 20

N-(2′-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells

de Oca, A. C.-M., Rodarte-Valle, E., Rosales‐Hernández, M. C., Abarca‐Rojano, E., Rojas-Hernández, S., Fragoso-Vázquez, M. J., Mendieta‐Wejebe, J. E., Correa-Basurto, A. M., Vásquez-Moctezuma, I., & Correa‐Basurto, J. (2018) · Oncotarget · doi:10.18632/oncotarget.26077 · Cited by 19

Hypoxia in the pathogenesis of preeclampsia

Matsubara, K. (2017) · Hypertension Research in Pregnancy · doi:10.14390/jsshp.hrp2017-014 · Cited by 20

Empowering hypoxia to convert cold tumors into hot tumors for breast cancer immunotherapy

Liu, L., Wu, D., Qian, Z., Ying, J., You, Y., Wang, Y., Zhang, F., Ning, X., Mei, J., Iqbal, J., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02682-8 · Cited by 20

H2O2 transit through the mitochondrial intermembrane space promotes tumor cell growth in vitro and in vivo

Sabharwal, S. S., Dudley, V. J., Landwerlin, C., & Schumacker, P. T. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104624 · Cited by 18

Role of A-Kinase anchor protein (AKAP4) in growth and survival of ovarian cancer cells

Kumar, V., Jagadish, N., & Suri, A. (2017) · Oncotarget · doi:10.18632/oncotarget.18163 · Cited by 18

NAD(P)HX epimerase downregulation promotes tumor progression through ROS/HIF‐1α signaling in hepatocellular carcinoma

Sun, B., Yu, L., Xu, C., Li, Y., Zhao, Y., Cao, M., & Yang, L. (2021) · Cancer Science · doi:10.1111/cas.14925 · Cited by 19

Advances in Antioxidant Applications for Combating 131I Side Effects in Thyroid Cancer Treatment

Li, Y., Ma, J., Lei, P., Yi, J., Ma, Y., Huang, Z., Wang, T., Ping, H., Ruan, D., Sun, D., et al. (2023) · Toxics · doi:10.3390/toxics11060529 · Cited by 17

Antioxidant Roles/Functions of Ascorbic Acid (Vitamin C)

Agwu, E., Ezihe, C. O., & Kaigama, G. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.110589 · Cited by 23

Vitamin C intake and risk of renal cell carcinoma: a meta-analysis

Li, J., Jia, Q., Shang, Y., Dong, X., & Li, L. (2015) · Scientific Reports · doi:10.1038/srep17921 · Cited by 17

CHCHD4 (MIA40) and the mitochondrial disulfide relay system.

Al-Habib, H., & Ashcroft, M. A. (2021) · Apollo (University of Cambridge) · doi:10.17863/cam.63568 · Cited by 16

Redox proteomics screening cellular factors associated with oxidative stress in hepatocarcinogenesis

Zhou, L., Ji, W., Huang, Z., Nice, E. C., Huang, C., Zhang, H., & Li, Q. (2016) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201600089 · Cited by 16

Impact of Static Magnetic Fields (SMFs) on Cells

Zhang, X., Yarema, K. J., & Xu, A. (2017) · Springer eBooks · doi:10.1007/978-981-10-3579-1_4 · Cited by 16

Ascorbate sensitizes human osteosarcoma cells to the cytostatic effects of cisplatin

Oka, N., Komuro, A., Amano, H., Dash, S., Honda, M., Ota, K., Nishimura, S., Ueda, T., Akagi, M., & Okada, H. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.632 · Cited by 16

Redox regulation of immunity and the role of small molecular weight thiols

Ghezzi, P. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102001 · Cited by 16

TSGA10 Over Expression Decreases Metastasic and Metabolic Activity by Inhibiting HIF-1 in Breast Cancer Cells

Jahani, M., Shahlaei, M., Norooznezhad, F., Miraghaee, S., Hosseinzadeh, L., Moasefi, N., Khodarahmi‬, R., Farokhi, A., Mahnam, A., & Mansouri, K. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.12.002 · Cited by 15

The expanding universe of hypoxia

Zhang, H., & Semenza, G. L. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0364-9 · Cited by 17

The expression of neuroglobin in astrocytoma

Qin, H., Guo, Y., Zhang, C., Zhang, L., Li, M., & Guan, P. (2011) · Brain Tumor Pathology · doi:10.1007/s10014-011-0066-9 · Cited by 16

The “Sharp”blade against HIF-mediated metastasis

Amelio, I., & Melino, G. (2012) · Cell Cycle · doi:10.4161/cc.22820 · Cited by 15

Intersecting Mechanisms of Hypoxia and Prostaglandin E2-Mediated Inflammation in the Comparative Biology of Oral Squamous Cell Carcinoma

Nasry, W. H. S., & Martin, C. K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.539361 · Cited by 16

Mitochondrial bioenergetics and networks in melanoma: an update

Giannitti, G., Paganoni, A. J. J., Marchesi, S., Garavaglia, R., & Fontana, F. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02155-4 · Cited by 15

Glycerol-weighted chemical exchange saturation transfer nanoprobes allow 19F/1H dual-modality magnetic resonance imaging-guided cancer radiotherapy

Rong, A., Wang, H., Nie, C., Han, Z., Zhou, M., Atinuke, O. O., Wang, K., Wang, X., Liu, S., Zhao, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42286-3 · Cited by 14

TSGA10 as a Potential Key Factor in the Process of Spermatid Differentiation/Maturation: Deciphering Its Association with Autophagy Pathway

Asgari, R., Bakhtiari, M., Rezazadeh, D., Yarani, R., Esmaeili, F., & Mansouri, K. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00648-6 · Cited by 14

The dual role of vitamin C in cancer: from antioxidant prevention to prooxidant therapeutic applications

Cao, X., Yi, Y., Ji, M., Liu, Y., Wang, D., & Zhu, H. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1633447 · Cited by 13

Associations between HIFs and tumor immune checkpoints: mechanism and therapy

Liu, J., Jiang, Y., Chen, L., Qian, Z., & Zhang, Y. (2024) · Discover Oncology · doi:10.1007/s12672-023-00836-7 · Cited by 13

Metastatic Breast Cancer, Organotropism and Therapeutics: A Review

Waza, A. A., Tarfeen, N., Majid, S., Hassan, Y., Mir, R., Rather, M. Y., & Shah, N. U. D. (2021) · Current Cancer Drug Targets · doi:10.2174/1568009621666210806094410 · Cited by 13

Imidazole‐based alkaloid derivative LCB 54‐0009 suppresses ocular angiogenesis and lymphangiogenesis in models of experimental retinopathy and corneal neovascularization

Kim, B., Lee, J., Choi, J., Park, D. Y., Song, H. Y., Park, T. K., Cho, C., Ye, S., Joo, C., Koh, G. Y., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13177 · Cited by 13

DHL-TauZnNa, a newly synthesized α-lipoic acid derivative, induces autophagy in human colorectal cancer cells

Hiratsuka, T., Inomata, M., Kono, Y., Yokoyama, S., Shiraishi, N., & Kitano, S. (2013) · Oncology Reports · doi:10.3892/or.2013.2394 · Cited by 13

Chronic CSE Treatment Induces the Growth of Normal Oral Keratinocytes via PDK2 Upregulation, Increased Glycolysis and HIF1α Stabilization

Sun, W., Chang, S. S., Fu, Y., Liu, Y., & Califano, J. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016207 · Cited by 13

实体瘤细胞中低氧诱导因子-1蛋白的活性调控

Bin, T. A. N. G., XiuMei, Z. H. O. U., & QiJun, Q. I. A. N. (2009) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/972009-495 · Cited by 13

Synthesis, characterization and biological activity of new cyclometallated platinum( iv ) complexes containing a para -tolyl ligand

Solé, M., Balcells, C. D., Crespo, M., Quirante, J., Badı́a, J., Baldomà, L., Font‐Bardía, M., & Cascante, M. (2018) · Dalton Transactions · doi:10.1039/c8dt01124a · Cited by 13

Progressive tumor growth-associated altered tumor microenvironment: implications in a tumor stage-dependent modulation in survival of a murine T cell lymphoma

Singh, V., & Singh, S. M. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0537-5 · Cited by 12

Depletion of SAM50 Specifically Targets BCR-ABL-Expressing Leukemic Stem and Progenitor Cells by Interfering with Mitochondrial Functions

Capala, M. E., Pruis, M. G. M., Vellenga, E., & Schuringa, J. J. (2016) · Stem Cells and Development · doi:10.1089/scd.2015.0151 · Cited by 12

The Molecular Role of HIF1α Is Elucidated in Chronic Myeloid Leukemia

Singh, V. K., Singh, R., Kushwaha, R., Verma, S. P., Tripathi, A. K., & Mahdi, A. A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.912942 · Cited by 11

Regulating Effect Of Carnosine And /Or L- Arginine On The Expression Of Inflammatory Molecules Induced Nephropathy In The Hypoxic Rat Model

Al-Rasheed, N. M., Fadda, L. M., Mohamed, A. M., Attia, H., Al‐Rasheed, N. M., & Mansoura Univrsity, E. (2016) · Brazilian Archives of Biology and Technology · doi:10.1590/1678-4324-2016150622 · Cited by 11

Oxidative Stress and the Intersection of Oncogenic Signaling and Metabolism in Squamous Cell Carcinomas

Choe, J. H., Mazambani, S., Kim, T. H., & Kim, J. (2021) · Cells · doi:10.3390/cells10030606 · Cited by 14

Molecular alterations that precede the establishment of the hallmarks of cancer: An approach on the prevention of hepatocarcinogenesis

Alarcón‐Sánchez, B. R., Pérez‐Carreón, J. I., Villa‐Treviño, S., & Arellanes‐Robledo, J. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114818 · Cited by 12

Vitamin C Against Cancer

Mastrangelo, D., Massai, L., Fioritoni, G., & Lo‐Coco, F. (2017) · InTech eBooks · doi:10.5772/intechopen.68746 · Cited by 13

Thioredoxin‐interacting protein is a favored target of miR‐125b, promoting metastasis and progression of pancreatic cancer via the HIF1α pathway

Wang, P., Zheng, D., Qi, H., & Gao, Q. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22782 · Cited by 11

Regulation of Hypoxia Dependent Reprogramming of Cancer Metabolism: Role of HIF-1 and Its Potential Therapeutic Implications in Leukemia

Pandey, S., Singh, R., Habib, N., Tripathi, R., Kushwaha, R., & Mahdi, A. A. (2024) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2024.25.4.1121 · Cited by 11

Downregulation of malic enzyme 3 facilitates progression of gastric carcinoma via regulating intracellular oxidative stress and hypoxia-inducible factor-1α stabilization

Huang, Y., Yang, Y. L., Chen, X., Zeng, S., Chen, Y., Wang, H., Lv, X., Hu, X., & Teng, L. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05388-9 · Cited by 10

Spermidine antagonizes the anti-cancer effect of cold atmospheric plasma and induces transit G0/G1 cell cycle arrest of triple negative breast cancers

Shen, L., Lv, X., Li, Y., & Dai, X. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.01.024 · Cited by 10

The Role of 2-Oxoglutarate-Dependent Oxygenases in Hypoxia Sensing

Wilkins, S. E., Flashman, E., Scotti, J. S., Hopkinson, R. J., Chowdhury, R., & Schofield, C. J. (2015) · Royal Society of Chemistry eBooks · doi:10.1039/9781782621959-00169 · Cited by 10

STC2 is a potential biomarker of hepatocellular carcinoma with its expression being upregulated in Nrf1α-deficient cells, but downregulated in Nrf2-deficient cells

Bu, Q., Deng, Y., Wang, Q., Deng, R., Hu, S., Pei, Z., & Zhang, Y. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127575 · Cited by 10

Cell type-dependent modulation of the gene encoding heat shock protein HSPA2 by hypoxia-inducible factor HIF-1: Down-regulation in keratinocytes and up-regulation in HeLa cells

Habryka, A., Gogler‐Pigłowska, A., Sojka, D. R., Kryj, M., Krawczyk, Z., & Ścieglińska, D. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.07.004 · Cited by 10

Current Limitations of Murine Models in Oncology for Ascorbate Research

Campbell, E. J., & Dachs, G. U. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00282 · Cited by 10

15-Deoxy-Δ12,14-prostaglandin J2stabilizes hypoxia inducible factor-1α through induction of heme oxygenase-1 and direct modification ofprolyl-4-hydroxylase 2

Choi, J.-E., Kim, J., Song, N., Suh, J., Kim, D.-H., Kim, S., Na, H., Nadas, J., Dong, Z., Cha, Y.-N., et al. (2016) · Free Radical Research · doi:10.1080/10715762.2016.1219352 · Cited by 10

Commentary: Antioxidants for Cancer: New Tricks for an Old Dog?

Sharifi, N. (2009) · The Oncologist · doi:10.1634/theoncologist.2008-0219 · Cited by 10

A MYC-controlled redox switch protects B lymphoma cells from EGR1-dependent apoptosis

Yao, H., Chen, X., Wang, T., Kashif, M., Qiao, X., Tüksammel, E., Larsson, L., Okret, S., Sayin, V. I., Qian, H., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112961 · Cited by 9

Development of small molecule inhibitors of hypoxia-inducible factors for cancer therapy

Semenza, G. L. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100075 · Cited by 10

A Clinician's Guide to Integrative Oncology

O’Brien, K., & Sali, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-56632-0 · Cited by 9

Advances in nanotechnology-related strategies against melanoma

Pinho, J. O., Lopes, J., Albino, M., Reis, C. P., Matias, M., & Gaspar, M. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85666-9.00009-7 · Cited by 9

Design of cysteine-based self-assembling polymer drugs for anticancer chemotherapy

Koda, Y., & Nagasaki, Y. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112909 · Cited by 9

HIF1A as a major vascular endothelial growth factor regulator: do its polymorphisms have an association with age‐related macular degeneration?

Okur, V., ÇETİN, O., Çetin, E. N., Tepeli, E., Bulğu, Y., & Yıldırım, C. (2014) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12376 · Cited by 9

Comparative study of antioxidants as cancer preventives through inhibition of HIF-1 alpha activity

Upadhyay, J., Kesharwani, R. K., & Misra, K. (2009) · Bioinformation · doi:10.6026/97320630004233 · Cited by 21

Reactive oxygen species regulate hypoxia-inducible factor HIF1a differentially in cancer and ischemia

Qutub, A. A., & Popel, E. S. (2008)

Regulation of hypoxia-inducible factor HIF1α through metabolic and oxidative pathways.

Qutub, A. A., & Popel, A. S. (2006) · Cancer Epidemiology and Prevention Biomarkers

Reactive Oxygen Species Regulate Hypoxia-Inducible Factor 1α Differentially in Cancer and Ischemia

Qutub, A. A., & Popel, A. S. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00060-08 · Cited by 196

Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.

Martínez-Sánchez, G., & Giuliani, A. (2007) · PubMed · Cited by 45